Why the study?
Is primary aldosteronism associated with worse renal impairment compared to essential hypertension, and how do targeted treatments affect GFR?
Population
816 subjects, comprising 408 patients with primary aldosteronism from the German Conn's Registry and 408…
Comparison
Primary aldosteronism; subsequent targeted… vs Hypertensive control subjects matched for age…
Design
Case-control
Authors
Loading...
PA may mask renal impairment vs essential hypertension; leaves open whether post-adrenalectomy GFR decline signals harm or unmasking.
Is primary aldosteronism associated with worse renal impairment compared to essential hypertension, and how do targeted treatments affect GFR?
Primary aldosteronism is associated with a higher prevalence of renal impairment compared to essential hypertension, and targeted treatments like adrenalectomy or spironolactone unmask this by causing a further decline in GFR.
Reincke et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: